Matches in SemOpenAlex for { <https://semopenalex.org/work/W2890904446> ?p ?o ?g. }
Showing items 1 to 72 of
72
with 100 items per page.
- W2890904446 endingPage "8022" @default.
- W2890904446 startingPage "8022" @default.
- W2890904446 abstract "8022 Background: KRd is approved for treatment of RRMM patients (pts). Under the approved KRd regimen, carfilzomib is given twice weekly (20/27 mg/m2; 10-min IV infusion). Here we present updated results from a dose-finding study assessing weekly KRd. Methods: This study consisted of a dose-evaluation component and a dose-expansion component in both RRMM and newly diagnosed MM. Results for RRMM pts are presented here. Two dose levels were evaluated: carfilzomib 56 mg/m2 and carfilzomib 70 mg/m2. All pts received carfilzomib (30-min IV infusion on days [D] 1, 8, and 15; 20 mg/m2 on C1D1), lenalidomide 25 mg (D1–21), and dexamethasone 40 mg (D1, 8, 15, and 22) on a 28-day cycle (dexamethasone was not given on D22 for cycles 9+). Pts in the expansion arm received the selected KRd regimen on the same schedule used for dose evaluation. Response was assessed by investigators. Results: Twenty-two RRMM pts were enrolled in the dose-evaluation part and received study drug (56 mg/m2, n = 10; 70 mg/m2, n = 12). The maximum tolerated dose of carfilzomib was not reached; the 70 mg/m2 dose was selected for dose expansion and 34 additional RRMM pts received this dose. Results are presented for pts who received carfilzomib 56 mg/m2 during dose evaluation (n = 10; median 2 prior regimens [range 1-3]) and for pts who received carfilzomib 70 mg/m2 during dose evaluation or expansion (n = 46; median 1 prior regimen [range 1-5]). Median (mean) average carfilzomib dose was 53.2 (52.8) mg/m2 in the 56 mg/m2 group and 62.4 (61.3) mg/m2 in the 70 mg/m2 group. Pt incidence of grade ≥3 adverse events was 70.0% (56 mg/m2) and 71.7% (70 mg/m2). Pt incidence of carfilzomib discontinuation due to adverse events was 20.0% (56 mg/m2) and 17.4% (70 mg/m2). There were three total deaths in the 70 mg/m2 group (one each due to cardiac arrest, cardiac disorder, and progressive disease). Overall response rates were 90.0% (56 mg/m2) and 89.1% (70 mg/m2); 20.0% (56 mg/m2) and 30.4% (70 mg/m2) of pts achieved a complete response (CR) or stringent CR. Conclusions: Once weekly KRd was effective and had manageable toxicity in pts with RRMM. As a weekly carfilzomib dosing regimen could offer pts greater convenience, these results support further clinical evaluation. Clinical trial information: NCT02335983." @default.
- W2890904446 created "2018-09-27" @default.
- W2890904446 creator A5013411479 @default.
- W2890904446 creator A5023752321 @default.
- W2890904446 creator A5028884212 @default.
- W2890904446 creator A5043322435 @default.
- W2890904446 creator A5050097218 @default.
- W2890904446 creator A5050961257 @default.
- W2890904446 creator A5051483089 @default.
- W2890904446 creator A5053833961 @default.
- W2890904446 creator A5087799564 @default.
- W2890904446 creator A5091043853 @default.
- W2890904446 date "2018-05-20" @default.
- W2890904446 modified "2023-10-17" @default.
- W2890904446 title "Weekly carfilzomib, lenalidomide, and dexamethasone (KRd) in relapsed or refractory multiple myeloma (RRMM): A phase 1b study." @default.
- W2890904446 doi "https://doi.org/10.1200/jco.2018.36.15_suppl.8022" @default.
- W2890904446 hasPublicationYear "2018" @default.
- W2890904446 type Work @default.
- W2890904446 sameAs 2890904446 @default.
- W2890904446 citedByCount "2" @default.
- W2890904446 countsByYear W28909044462020 @default.
- W2890904446 countsByYear W28909044462023 @default.
- W2890904446 crossrefType "journal-article" @default.
- W2890904446 hasAuthorship W2890904446A5013411479 @default.
- W2890904446 hasAuthorship W2890904446A5023752321 @default.
- W2890904446 hasAuthorship W2890904446A5028884212 @default.
- W2890904446 hasAuthorship W2890904446A5043322435 @default.
- W2890904446 hasAuthorship W2890904446A5050097218 @default.
- W2890904446 hasAuthorship W2890904446A5050961257 @default.
- W2890904446 hasAuthorship W2890904446A5051483089 @default.
- W2890904446 hasAuthorship W2890904446A5053833961 @default.
- W2890904446 hasAuthorship W2890904446A5087799564 @default.
- W2890904446 hasAuthorship W2890904446A5091043853 @default.
- W2890904446 hasConcept C126322002 @default.
- W2890904446 hasConcept C126894567 @default.
- W2890904446 hasConcept C143998085 @default.
- W2890904446 hasConcept C2776063141 @default.
- W2890904446 hasConcept C2776364478 @default.
- W2890904446 hasConcept C2780108899 @default.
- W2890904446 hasConcept C2780401358 @default.
- W2890904446 hasConcept C2781413609 @default.
- W2890904446 hasConcept C71924100 @default.
- W2890904446 hasConceptScore W2890904446C126322002 @default.
- W2890904446 hasConceptScore W2890904446C126894567 @default.
- W2890904446 hasConceptScore W2890904446C143998085 @default.
- W2890904446 hasConceptScore W2890904446C2776063141 @default.
- W2890904446 hasConceptScore W2890904446C2776364478 @default.
- W2890904446 hasConceptScore W2890904446C2780108899 @default.
- W2890904446 hasConceptScore W2890904446C2780401358 @default.
- W2890904446 hasConceptScore W2890904446C2781413609 @default.
- W2890904446 hasConceptScore W2890904446C71924100 @default.
- W2890904446 hasIssue "15_suppl" @default.
- W2890904446 hasLocation W28909044461 @default.
- W2890904446 hasOpenAccess W2890904446 @default.
- W2890904446 hasPrimaryLocation W28909044461 @default.
- W2890904446 hasRelatedWork W1985864219 @default.
- W2890904446 hasRelatedWork W2093665884 @default.
- W2890904446 hasRelatedWork W2118465399 @default.
- W2890904446 hasRelatedWork W2892083382 @default.
- W2890904446 hasRelatedWork W2979804295 @default.
- W2890904446 hasRelatedWork W3032992174 @default.
- W2890904446 hasRelatedWork W3094792334 @default.
- W2890904446 hasRelatedWork W4245786844 @default.
- W2890904446 hasRelatedWork W4387003896 @default.
- W2890904446 hasRelatedWork W4387077574 @default.
- W2890904446 hasVolume "36" @default.
- W2890904446 isParatext "false" @default.
- W2890904446 isRetracted "false" @default.
- W2890904446 magId "2890904446" @default.
- W2890904446 workType "article" @default.